- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 475/02 - Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
Patent holdings for IPC class C07D 475/02
Total number of patents in this class: 45
10-year publication summary
|
2
|
5
|
5
|
5
|
0
|
2
|
1
|
2
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2222 |
6 |
| Janus Biotherapeutics, Inc. | 10 |
3 |
| Boehringer Ingelheim International GmbH | 4493 |
2 |
| University of Florida Research Foundation, Inc. | 4174 |
2 |
| Chiesi Farmaceutici S.p.A. | 959 |
2 |
| Monash University | 733 |
2 |
| RespiVert Ltd. | 79 |
2 |
| The University of Florida Board of Trustees, a Public Body Corporate of the State of Florida | 79 |
2 |
| The University of Melbourne | 569 |
2 |
| The University of Queensland | 661 |
2 |
| Guangdong Raynovent Biotech Co., Ltd. | 52 |
2 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| Hoffmann-La Roche Inc. | 3793 |
1 |
| AstraZeneca AB | 2814 |
1 |
| The General Hospital Corporation | 4870 |
1 |
| Takeda Pharmaceutical Company Limited | 2712 |
1 |
| Ewha University-industry Collaboration Foundation | 801 |
1 |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd | 25 |
1 |
| Kissei Pharmaceutical Co., Ltd. | 178 |
1 |
| Korea University Research and Business Foundation | 3266 |
1 |
| Other owners | 9 |